首页> 外文期刊>Indian journal of psychiatry >INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
【24h】

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC

机译:锂和神经脂联合治疗对神经病致残综合征的发生风险增加

获取原文
           

摘要

Whether there is an increased risk of occurrence of neuroleptic malignant syndrome (NMS) on combined treatment with lithium and neuroleptic is a controversial issue. Patients seen in a general psychiatry unit of a university hospital in India were prospectively screened for NMS over a 2 year period. Diagnosis of NMS was made on operational criteria and the details of treatment at the time of occurrence of NMS were collected systematically. Eight cases of NMS were identified during the period of the study, out of which 5 (62.5%). were taking lithium and a neuroleptic together at the time of occurrence of NMS. The high prevalence of patients on lithium and neuroleptic concomitantly in our sample of NMS, and the similar findings in many of the earlier prospective studies, makes it possible to speculate whether there is an association between combined use of lithium and neuroleptic and occurrence of NMS. Findings are discussed.Keywords: NMS, lithium, neuroleptics
机译:锂和神经安定剂联合治疗是否会增加神经安定剂恶性综合征(NMS)发生的风险是一个有争议的问题。在印度的一家大学医院的普通精神病学部门就诊的患者经过2年的前瞻性筛查。根据操作标准对NMS进行诊断,并系统收集NMS发生时的治疗细节。在研究期间鉴定出8例NMS,其中5例(62.5%)。在发生NMS时同时服用锂和抗精神病药。在我们的NMS样本中,患者同时使用锂和精神安定药的患病率很高,并且在许多较早的前瞻性研究中也发现了类似的发现,这使得我们有可能推测锂和精神安定药的联合使用与NMS的发生之间是否存在关联。关键词:NMS,锂,抗精神病药

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号